showed a trendP = 0.0906
Embryonic myr-AKT-AAV1 treatment also showed a trend for amelioration of invasion volume under a setting of 20% FBS w/o HI albeit without a statistical significance ( P = 0.0906) (Supplementary Fig. 9H–K ), suggesting a partial efficacy of AKT1 transduction to alleviate the defects by COX-2 insufficiency and also its limitation to recover other unknown defects with FBS.